Endogenex
@endogenex
Followers
58
Following
5
Media
23
Statuses
56
Signaling a new era in T2D therapy
Plymouth, MN
Joined April 2021
Excited to present REGENT-1 study data at #ADA2025 this week in Chicago!.New findings highlight the potential of our pulsed electric field (PEF) system to impact:.✅ Insulin sensitivity.✅ Beta cell function.✅ Dose responsivity. #Type2Diabetes #Endogenex #ReCETStudy.
1
0
0
Groundbreaking data at #DDW2025:.AI-driven 3D spatial analysis reveals profound immune dysregulation and structural remodeling in T2D duodenums. Presented by @babudayyeh, the first-of-its-kind abstract marks a major advance in understanding diabetic duodenopathy. #T2D #duodenum
0
1
5
Endogenex announces 48-week REGENT-1 study data presented at #DDW2025 by @babudayyeh shows durable reduction in insulin resistance and improved beta cell function in T2D patients. #DDW2025 #ReCET #duodenum #duodenopathy
1
2
12
RT @MayoStudies: Mayo Clinic researchers are seeking volunteers ages 22-70 with a BMI between 27-40 for a randomized study of a device used….
0
2
0
Endogenex is adding to its leadership team. We are excited to announce Krissy Wright as the new Chief Financial Officer. #diabetes #GItwitter
0
0
1
Great #ReCETStudy progress ! Kudos to @OrlandoHealth and clinical team for advancing study of mucosal regeneration. Keep up the great work!.Learn about the #ReCETStudy: Explore ReCET Therapy: #T2D #Duodenum #DiabeticDuodenopathy.
0
0
2
Exciting News! Endogenex announces enrollment of the first patient in the ReCET Clinical Study. Led by Dr. Andre Teixeira at Orlando Health, this milestone marks a significant step in our mission to transform diabetes care. Read more in our press release below. 👇.
1
0
1
RT @babudayyeh: A new paradigm suggesting that the integrative function of the duodenum in orchestrating the metabolic response is altered….
0
6
0
Exciting times at @endogenex . We are proud to announce the completion of our $88 million Series C financing. Congratulations to the team!.#GItwitter #ReCET #type2diabetes #gastroenterology #endocrinology.
0
1
1
A full weekend of learning, presentations, & meetings at #ADA2024. Great to see the teams in person, & exciting for them to share clinical data during #ADAScientificsessions. *not for sale in any geography. #type2diabetes #ReCET #endocrionology #gastrenterology #endogenex
0
1
1
in Poster Hall A4-B2 of the Orlando Convention Center. *not for sale in any geography. Abstracts 881-P, 896-P, and 884-P.#type2diabetes #gitwitter #ReCET #endocrinology #gastroenterology
0
0
0
Congrats to @babudayyeh, David O’Neal, Celine Busch, and their research teams for your upcoming abstract presentations at the #ADA2024. Data detailing longer-term outcomes of investigational ReCET™ System* treating T2D will be presented on June 23rd, from 12:30 to 1:30 p.m. ET.
1
0
0
More clinical data from #DDW2024. @medicritic presents REGENT-1 AUS 48-week results of duodenal recellularization with ReCET System in people with T2D. Congratulations to the research team & their ongoing work. #type2diabetes #ReCET #GItwitter #gastrenterology #endocrinology
0
0
3
RT @MayoClinicGIHep: @babudayyeh presenting cutting-edge data on endoscopic therapy approaches to #diabetes management.A glimpse into the f….
0
1
0
REGENT-US & EMINENT clinical study results presented at #DDW2024.@babudayyeh presented REGENT study outcomes.Celine Busch presented 18-month results from the EMINENT Study. Great work by the research teams. #type2diabetes #GItwitter #gastroenterology #duodenum#recellularization
0
1
1
See us at #DDW2024 Washington DC on May 18 - 21 at Booth 522.EMINENT & REGENT study outcomes of ReCET treatment in patients with T2D to be presented on May 18th & 19th. #diabetestwitter #type2diabetes #endocrinology #GItwitter #duodenum #recellularization
0
0
0
Endogenex announces IDE approval of the ReCET Pivotal Clinical Study to treat adult patients with #type2diabetes. We are excited to achieve this important milestone and enter the next clinical phase. #ReCET #diabetesmanagement #GITwitter #endoscopy.
0
2
7